| |
 |
|
|
Bridgehead
International
US Expansion
continues
September 2008
Kevin Mayo joins Bridgehead International
New Jersey office
Kevin Mayo has joined Bridgehead
International as VP, Bridgehead USA Inc.
Kevin is a Health Economics and Market Access Strategist, with experience in pharmaceutical companies and payer organisations. Kevin is an adjunct professor for the University of the Sciences in Philadelphia's Graduate Program in Pharmaceutical Business where he teaches Health Economics and Pharmaceutical Pricing and Reimbursement courses. Kevin also serves as a co-chair for the Global Health Technology Assessment Used in HealthCare Reimbursement Working Group, a special interest group within the International Society for Pharmacoecomics and Outcomes Research (ISPOR) professional organization. Kevin's global pharmaceutical industry experience includes positions with Daiichi Sankyo Inc., Novartis Pharma AG, Pharmacia Corporation and Hoffmann La Roche
Kevin obtained his doctoral degree in Pharmaceutical Administration from the University of Louisiana at Monroe and completed a post-doctoral fellowship with the State University of New York-Buffalo, Millard Fillmore Healthcare Systems and the USA Federal Food and Drug Administration (FDA).
|
|
Bridgehead International CEO,
Timothy Fitzgerald commented: "We are delighted at
Kevin's decision to join the team. His expertise and experience,
particularly in health economics, market access and health
technology assessment, will be of real value to Bridgehead
and our clients."
Over the past four years Bridgehead's
Market Access business has grown to be the single largest
practice area in the company.
Whilst much of Bridgehead's work
on pricing, reimbursement and market access is global in nature
(US, top five Europe and Japan), the company is being asked
increasingly to use its knowledge and experience to address
US-specific issues, through:
- Payer research
- Therapy area scanning
- Pricing strategy for commercialisation
- Reimbursement negotiation strategy
- Product life cycle pricing strategy
- Pharmacoeconomic assessments
- Health technology assessment support
Top
|
About Bridgehead International
Bridgehead
International is a leading biopharmaceutical consultancy
group, offering a range of services designed to assist clients
in achieving extraordinary growth across the product and technology
value chain, through three practice areas:
- Market Access Solutions, including market
assessments and development of pricing and reimbursement
strategies.
- Technical and Commercial Evaluation,
covering due diligence, expert reports and decision support.
- Healthcare Education Services,
focused on specialist medical education for those working
in the pharmaceutical and biotechnology industry.
With over 50 consultants and associates
in Europe, North America and Asia, Bridgehead Consulting
provides a powerful combination of strategic, scientific,
medical, technical, commercial, economic, decision support,
modelling and intellectual property skills and experience.
|
